Past Events

In the past, obtaining an issued patent from the U.S. Patent and Trademark Office usually meant wrangling with a patent examiner over the pillars of patentability, novelty and obviousness. However, the Supreme Court's 2023 decision in Amgen v. Sanofi thrust another lesser-known condition, the enablement requirement, to the forefront. Citing the enablement requirement, the Court curtailed the breadth of the Amgen's patent claims, stating that the specification did not support their broad claims to classes of molecules. In the aftermath, inventors, patent holders and practitioners have been left scrambling to figure out how this new interpretation of enablement affects them.

Join us for a webinar with Yvonne Shyntum, Partner at PABST Patent Group, as she walks through the Court's interpretation of enablement and practical strategies for complying with enablement. Dr. Shyntum holds a Ph.D. in Molecular and Systems Pharmacology from Emory University and a J.D. from Georgia State University. She represents clients in the biotechnology and pharmaceutical areas and regularly presents on intellectual property topics. 

Register here. 

Applications are open for the Summer 2025 Prototyping Hardware Accelerator at Rev: Ithaca Startup Works! 

Over 10 weeks, Rev’s in-person Prototyping Hardware Accelerator guides product teams to determine if their ideas are commercially desirable, technologically feasible, and economically viable. Upon completion of the program, participants are positioned to recruit team members, bring on partners, initiate work with contract manufacturers, and pitch to investors. Teams will receive a stipend of up to $2,000 to advance their prototype. 

Want to learn more? Register to attend an upcoming virtual information session. Questions? Contact rev@revithaca.com.

In this hybrid course (February 10 - March 12), a select group of researchers working on digital healthcare technology will "get out of their comfort zone" and talk to customers at the Healthcare Information and Management Systems Society (HIMSS) conference to identify the best product-market fit. The course begins online and culminates with a trip to Las Vegas, NV for the 2025 HIMSS Conference. Up to $5,000 (depending on team size) in travel reimbursement funding will be available for accepted teams*.

You may apply with a team of 1-3 people. Teams may not split attendance between members. Please only include the members of your team that will be fully participating in the course. All team members are required to attend and participate fully in every course session and complete all coursework.

Apply here. Questions? Contact icorps@cornell.edu. 

Join us for a virtual info session for the Susan and Gene D. Resnick ’70, MD ’74 Prize for Excellence in Entrepreneurship (“Resnick Prize”). The Resnick Prize is an annual, university-wide competition that provides funding to startups with an active, intercampus collaboration involving Weill Cornell Medicine and another Cornell University location in Ithaca, New York, or Qatar. Startups initiated on the Weill Cornell, Cornell Ithaca, Cornell Tech, or Weill Cornell Medicine - Qatar campuses are eligible to apply as long as the startup has a license to Cornell-owned technology that touches Weill Cornell Medicine through either a research or clinical collaboration.

We are seeking exciting collaborations where teams can work together on a technology that will be commercialized via a startup. The winning company will receive up to $10,000 in prize money.

The Resnick Prize seeks to fund projects in all sectors (therapeutics, devices, digital health, research & AI tools, etc.) impacting healthcare and patient outcomes. Teams must have incorporated their company to be eligible for the award.  

Please RSVP for this info session to learn more about the application process and eligibility.